论文部分内容阅读
红桃 K 集团股份有限公司是经武汉市体改委批准设立的定向募集股份有限公司,位于东湖高新技术开发区。公司是以生物工程为主导产业,以研制开发、生产销售药品、保健品为主营业务,并涉足通讯、新材料、房地产等领域的高新技术股份有限公司。公司组建四年来,从没有厂房设备,没有生产技术基础,资金短缺,市场营销能力几乎为零的情况下起步,紧紧抓住卟啉铁强化补血剂这一生物技术最新成果,通过开展资本营运,实
Hongtao K Group Co., Ltd. is a directional fund-raising company limited by the approval of Wuhan Municipal Economic Reform Commission and is located in Donghu Hi-tech Development Zone. The company is a bio-engineering-oriented industry, which focuses on research, development, production and sales of pharmaceuticals and health products, and is involved in high-tech companies such as communications, new materials, and real estate. In the four years since the establishment of the company, it has started from the absence of plant and equipment, lack of production technology, capital shortage, and almost zero marketing capacity. It has firmly grasped the latest biotechnology achievements of porphyrin iron fortifying blood-supplementing agents and carried out capital operations. ,real